JPH08336549A - Container for artificial organs using apatite - Google Patents

Container for artificial organs using apatite

Info

Publication number
JPH08336549A
JPH08336549A JP16928295A JP16928295A JPH08336549A JP H08336549 A JPH08336549 A JP H08336549A JP 16928295 A JP16928295 A JP 16928295A JP 16928295 A JP16928295 A JP 16928295A JP H08336549 A JPH08336549 A JP H08336549A
Authority
JP
Japan
Prior art keywords
container
apatite
tissue
artificial organs
organ
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16928295A
Other languages
Japanese (ja)
Inventor
Katsunari Nishihara
西原克成
Kazushi Hirota
広田和士
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute for Research in Inorganic Material
Original Assignee
National Institute for Research in Inorganic Material
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institute for Research in Inorganic Material filed Critical National Institute for Research in Inorganic Material
Priority to JP16928295A priority Critical patent/JPH08336549A/en
Publication of JPH08336549A publication Critical patent/JPH08336549A/en
Pending legal-status Critical Current

Links

Landscapes

  • Prostheses (AREA)

Abstract

PURPOSE: To easily treat the organs of the lesion part by using a material having a function to reproduce autotissues. CONSTITUTION: At least the inside walls of this container for artificial organs are composed of the material consisting essentially of apatite. A material compounded with an org. material, such as collagen, under a condition of >=30wt.% of the apatite content is also usable as the material for the inside walls of the vessel. As a result, the container is used as the container for the artificial organs for freshly generating the organ tissues which are the autotissues in the treatment of the disease caused by the lesion of the organ tissues.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、人体や動物の体内に埋
め込まれるインプラント材として使用される人工臓器用
容器に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a container for artificial organ used as an implant material to be embedded in the human body or animal body.

【0002】[0002]

【従来の技術】治療技術の発展に伴って、各種の治療器
具や器材が開発され、使用されている。たとえば、体液
の解毒や内分泌を司る肝臓,副腎,脾臓等の内臓が病変
等によって機能不全を生じた際、その内臓に変わり得る
代替物が必要とされる。臓器組織の一部を移植,増殖さ
せる際、これらの組織が直接接触する容器の内壁を構成
する材質として、各種のプラスチックス,金属,ガラス
等の使用が試みられている。また、生体親和性を向上さ
せるために、材料表面に化学就職を施すことも検討され
ている。最近では、容器内壁にコラーゲンを被覆する
と、組織が活着しやすいとの報告もされている。
2. Description of the Related Art With the development of treatment technology, various treatment instruments and equipment have been developed and used. For example, when the liver, adrenal gland, spleen, and other internal organs that control detoxification and endocrine of body fluid become dysfunctional due to lesions, a substitute that can replace the internal organs is required. Attempts have been made to use various kinds of plastics, metals, glass, etc. as a material forming the inner wall of the container with which these tissues come into direct contact when a part of the organ tissues is transplanted or proliferated. Further, in order to improve biocompatibility, it is also considered to apply chemical employment to the material surface. Recently, it has been reported that when the inner wall of the container is coated with collagen, the tissue is easily activated.

【0003】[0003]

【発明が解決しようとする課題】このように内臓用の材
料として各種の材料が開発されているが、実用化にはほ
ど遠く、未だ基礎的な研究段階に止まっている。そのた
め、血液型が適合した個体間の臓器移植に大半頼らざる
を得ない現状である。しかし、個体間の臓器移植では、
適合性の問題が避けられず、また臓器提供する人を見つ
け出すことも容易ではない。本発明は、このような問題
を解消すべく案出されたものであり、臓器組織を収容
し、増殖させることが可能な材質としてアパタイトを使
用することにより、内臓器官の機能不全による病気の治
療を容易にすることを目的とする。
As described above, various materials have been developed as materials for internal organs, but they are far from practical use and are still at the basic research stage. Therefore, it is the current situation that most of them have to rely on organ transplantation among individuals with matched blood types. However, in organ transplants between individuals,
Compatibility issues are unavoidable, and finding the person to donate an organ is not easy. The present invention has been devised to solve such a problem, and by using apatite as a material capable of accommodating and proliferating organ tissues, the treatment of diseases caused by malfunction of internal organs. The purpose is to facilitate.

【0004】[0004]

【課題を解決するための手段】本発明の人工臓器用容器
は、その目的を達成するため、臓器の組織を収容する容
器であって、少なくとも容器内壁がアパタイトを主成分
とする材質で構成されていることを特徴とする。アパタ
イトの含有量30重量%以上の条件でコラーゲン等の有
機物質を配合した材料で、容器内壁の材質とすることも
できる。
In order to achieve the object, the container for artificial organs of the present invention is a container for containing the tissue of an organ, and at least the inner wall of the container is made of a material whose main component is apatite. It is characterized by A material in which an organic substance such as collagen is mixed under the condition that the apatite content is 30% by weight or more can be used as the material of the inner wall of the container.

【0005】[0005]

【作用】本発明者等は、インプラント材として使用可能
な材料について種々調査・研究してきた。その過程で、
アパタイトが特異な機能を発現することを見い出した。
すなわち、肝臓,副腎,脾臓等の組織の一部を実験動物
から切り取り、水酸化アパタイトからなる小容器に入
れ、小容器を実験動物の血管に接続し、血流が容器内の
組織を洗うように構成し、アパタイトの影響を調査・研
究した。その結果、各組織が増殖していることが観察さ
れた。この知見を基に実験を繰り返した結果、これら内
臓組織と直接接触する内壁にアパタイトを主成分とする
成形体を用いることが内臓組織を増殖させる上で重要で
あることが判った。この現象は、インプラント手術によ
って傷付けられた組織が治癒する過程で、未分化の細胞
がアパタイト多孔体内の環境で臓器組織を新たに作るこ
とに由来するものと推察される。
The present inventors have conducted various investigations and researches on materials that can be used as implant materials. In the process,
It was found that apatite expresses a unique function.
That is, a part of the tissues such as liver, adrenal gland, spleen, etc. is cut out from the experimental animal, placed in a small container made of hydroxyapatite, and the small container is connected to the blood vessel of the experimental animal so that blood flow will wash the tissue in the container , And investigated and studied the effect of apatite. As a result, it was observed that each tissue was growing. As a result of repeated experiments based on this finding, it was found that it is important to grow a visceral tissue by using a molded body containing apatite as the main component on the inner wall that directly contacts the visceral tissue. It is speculated that this phenomenon is derived from the fact that undifferentiated cells newly create organ tissue in the environment inside the apatite porous body in the process of healing the tissue damaged by implant surgery.

【0006】アパタイトに加えてコラーゲン等の有機物
を含む内壁を使用した場合、各内臓組織は良好に増殖し
ていた。これは、コラーゲン等の有機物による内臓組織
の育成がアパタイトによって促進されていることを示
す。しかし、アパタイトのない材料で形成した内壁で
は、組織の増殖が起こり難かった。このようなアパタイ
トの作用は、アパタイトを30重量%以上含む材料で容
器内壁を形成するときに有効となる。内臓組織を収容し
た容器には、血管を接続して容器内を豊かな血流で満た
すことが組織増殖の必要条件となる。この点で、中程度
の幹血管の径に相当する2mm程度から毛細血管の孔径
に相当する10μm以上の貫通孔をもつアパタイト多孔
体が好ましい。これら条件が満足されると、臓器組織片
は血流中で活発に活動,増殖して容器内空間を満たすよ
うに成育する。
When an inner wall containing an organic substance such as collagen in addition to apatite was used, each visceral tissue was well grown. This indicates that the growth of the visceral tissue by an organic substance such as collagen is promoted by apatite. However, it was difficult for the tissue to grow on the inner wall made of a material without apatite. The action of such apatite is effective when forming the inner wall of the container with a material containing 30% by weight or more of apatite. It is a necessary condition for tissue growth to connect a blood vessel to the container containing the visceral tissue and fill the container with a rich blood flow. In this respect, an apatite porous body having a through hole of about 2 mm corresponding to the diameter of a medium-sized stem blood vessel and 10 μm or more corresponding to the pore diameter of a capillary is preferable. When these conditions are satisfied, the organ tissue piece actively activates and proliferates in the bloodstream and grows to fill the space inside the container.

【0007】[0007]

【実施例】室温で水酸化カルシウム懸濁液を撹拌し、こ
れにリン酸水溶液を注入して化学量論比のアパタイト粉
末を合成した。この結晶粒径は、長さ100nm,太さ
20nmであった。この粉末を金属封管に封入し、排気
した。この封管を700℃,600MPaに2時間保持
することにより、アパタイト焼結体を製作した。得られ
た焼結体の平均結晶粒径は約30nmであった。このよ
うにして、長さ50mm,幅40mm及び厚み8mmの
長方形状の水酸アパタイト焼結体を得た。このアパタイ
ト焼結体の内部に内径2〜5mmの櫛型状流路を形成
し、流路の末端に金属チタン製の管を固定し、血流の流
出口及び流入口とした。流路の一部に小腔を設け、成犬
から摘出した米粒大の肝臓片を植え付けた。このように
構成された水酸化アパタイト焼結体製容器を、肝臓片の
摘出に用いた成犬の大腿部に固定した。そして、容器中
の肝臓組織片に血流が保たれるように、大腿動脈を切断
して得られた血管の切り口を各金属チタン製管の両端部
に接続した。成犬に付けた傷部を閉鎖した後、健康状態
で飼育した。8週間経過後、摘出して容器内を検査し
た。顕微鏡観察の結果、容器内の流路全体が肝臓組織で
満たされ、その中を再生した血管組織が貫通しているこ
とが確認された。
[Examples] A calcium hydroxide suspension was stirred at room temperature, and an aqueous phosphoric acid solution was injected thereinto to synthesize stoichiometric apatite powder. The crystal grain size was 100 nm in length and 20 nm in thickness. This powder was sealed in a metal sealed tube and evacuated. By holding this sealed tube at 700 ° C. and 600 MPa for 2 hours, an apatite sintered body was manufactured. The average crystal grain size of the obtained sintered body was about 30 nm. Thus, a rectangular hydroxyapatite sintered body having a length of 50 mm, a width of 40 mm and a thickness of 8 mm was obtained. A comb-shaped flow channel having an inner diameter of 2 to 5 mm was formed inside the apatite sintered body, and a metal titanium tube was fixed to the end of the flow channel to serve as a blood flow outlet and an inlet. A small cavity was provided in a part of the flow path, and a rice grain-sized liver piece extracted from an adult dog was planted. The hydroxyapatite sintered body container thus configured was fixed to the thigh of the adult dog used for extracting the liver piece. Then, incisions of the blood vessels obtained by cutting the femoral artery were connected to both ends of each metallic titanium tube so that blood flow was maintained in the liver tissue pieces in the container. After closing the wound on the adult dog, the dog was kept in a healthy condition. After the lapse of 8 weeks, the contents were extracted and the inside of the container was inspected. As a result of microscopic observation, it was confirmed that the entire flow path in the container was filled with liver tissue, and the regenerated vascular tissue penetrated therein.

【0008】[0008]

【発明の効果】以上に説明したように、本発明の人工臓
器用容器は、臓器組織を生成及び育成するアパタイトの
機能を利用し、臓器組織の病変によって生じた病気の治
療に自家組織である臓器組織を新たに発生させる人工臓
器用インプラント材として使用される。そのため、異な
る個体の臓器を移植するために血液型の適合者を捜し出
す困難な作業が回避され、病気治療が容易になる。
As described above, the container for artificial organs of the present invention utilizes the function of apatite for producing and growing organ tissues and is a self-organized tissue for treating diseases caused by lesions of organ tissues. Used as an implant material for artificial organs that newly generate organ tissues. Therefore, it is possible to avoid the difficult work of finding a blood type matching person in order to transplant an organ of a different individual, thereby facilitating disease treatment.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 臓器の組織を収容する容器であって、少
なくとも容器内壁がアパタイトを主成分とする材質で構
成されている人工臓器用容器。
1. A container for accommodating tissue of an organ, wherein at least the inner wall of the container is made of a material whose main component is apatite.
【請求項2】 請求項1記載の容器内壁がコラーゲン等
の有機物質を配合したアパタイトからなり、アパタイト
の含有量が30重量%以上である人工臓器用容器。
2. A container for artificial organs, wherein the inner wall of the container according to claim 1 is made of apatite mixed with an organic substance such as collagen, and the apatite content is 30% by weight or more.
JP16928295A 1995-06-12 1995-06-12 Container for artificial organs using apatite Pending JPH08336549A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16928295A JPH08336549A (en) 1995-06-12 1995-06-12 Container for artificial organs using apatite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16928295A JPH08336549A (en) 1995-06-12 1995-06-12 Container for artificial organs using apatite

Publications (1)

Publication Number Publication Date
JPH08336549A true JPH08336549A (en) 1996-12-24

Family

ID=15883632

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16928295A Pending JPH08336549A (en) 1995-06-12 1995-06-12 Container for artificial organs using apatite

Country Status (1)

Country Link
JP (1) JPH08336549A (en)

Similar Documents

Publication Publication Date Title
JP5053470B2 (en) Graft prosthesis and materials and methods thereof
Epple et al. Prefabrication of a large pedicled bone graft by engineering the germ for de novo vascularization and osteoinduction
JP2005521405A5 (en)
US20150094808A1 (en) Synthetic scaffolds and organ and tissue transplantation
EP3338818A1 (en) Bone repair reusable composite material based on acellular biological tissue matrix material and preparation method therefor
JP2003517858A (en) Augmentation and repair of age-related soft tissue defects
EP3162385B1 (en) Implant cultured periodontal ligament cell sheet complex
ATE376356T1 (en) PACKAGING FOR CRYOPRESERVATION AND STORAGE OF CULTURED TISSUE EQUIVALENTS
KR102269612B1 (en) Lipofilling with ex-vivo expanded adipose tissue-derived stem cells for cosmetic breast filling or for facial filling and/or rejuvenation
KR20010094058A (en) Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
JPS60253455A (en) Living body material containing bone forming factor
CA1142430A (en) Bone substitute material and its use
WO2003041607A1 (en) Method of cell taking on surface of article with three-dimensional structure
JPH0149501B2 (en)
Krasnikov et al. Analysis of dental implants' biointegration in animals
KR20010048219A (en) Process for manufacturing of bone graft materials using animal bones
WO2003070290A1 (en) Composite biomaterial containing phospholine
EP0049341B1 (en) Process for conditioning alloplastic implantations and transplantations
JPH01212559A (en) Biological implant substance
CN1241652C (en) Artificial bone material
CN104127913A (en) Medical composite material with improved osseointegration performance
Păun et al. The use of collagen-coated polypropylene meshes for nasal reconstructive surgery
JPH08336549A (en) Container for artificial organs using apatite
WO2017101021A1 (en) Modified bone repairing material
Cummine et al. Osteogenesis after bone and bone-marrow transplantation: I. Studies with combined myelo-osseous grafts in the guinea pig